Recruiting

Onset of Sensory Block After Thoracic ESP Block

The goal of this observational study is to to evaluate the changes in cold sensitivity and the onset of sensory block after performing a thoracic ESP block. It reflects the time it takes for the local anaesthetic to spread into the paravertebral space leading to changes in cold sensitivity in the chest. The study population are patients undergoing simple quadrantectomy or partial resection with or without sentinel lymphnode removal, in the operating rooms of Santa Maria Goretti Hospital in Latina. This study is…

ClinicalTrials.gov IDNCT06642142
PhaseNot Applicable
Enrollment30
SponsorOspedale Santa Maria Goretti
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Breast Cancer Surgery, ESPB

About this study

The goal of this observational study is to to evaluate the changes in cold sensitivity and the onset of sensory block after performing a thoracic ESP block. It reflects the time it takes for the local anaesthetic to spread into the paravertebral space leading to changes in cold sensitivity in the chest. The study population are patients undergoing simple quadrantectomy or partial resection with or without sentinel lymphnode removal, in the operating rooms of Santa Maria Goretti Hospital in Latina. This study is observational because it simply describes and records the effects of a procedure (the ESP block) on treated patients during a period of observation. Before surgery, unilateral thoracic ESP block (T4 level) with a sterile, ultrasound-guided technique will be performed. A timer will be started to mark the time for subsequent evaluations. At 1,3,5 and after every 5 minutes following the block up to 40 minutes or until induction of general anaesthesia, the cold sensitivity of the chest will be explored.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Age ≥ 18 years. * ASA score I-II-III. * Schedule of breast surgery * Schedule of ESPB * Consent to the study Exclusion Criteria: * Allergy to local anaesthetics * Cardiopathies, nephropathies, hepatopathies, central or peripheral neuropathies uncompensated * Infection at the injection site * Uncooperative patient * BMI \< 20, \> 40 * Difficulty in visualising target structures or the LA spread (failure of technique) * Pregnancy status

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.